|
|
|
|
|
|
|
|
Timetable
|
Thursday, January 28
| 12:00 |
Registration Opens |
| 16:00-17:15 |
Satellite Symposium: 16:00 - 17:15
New Clinical Evidence for Visceral Fat Reduction and Related Health Implications Sponsored by GSK
16:00 - 16:15: Welcome & Introductions R. Mishra
16:15 - 16:30: Translating Emerging Science into Clinical Practice J. Albu
16:30 - 16:45: The Impact of Orlistat (alli) 60mg on Visceral Fat: Imaging Data from an Open-Label MRI Clinical Trial J. Bell
16:45 - 17:00: The Impact of Orlistat (alli) 60mg on Visceral Fat: Data From a Randomized, Controlled Clinical Trial K. Stenlof
17:00 - 17:15: Q & A (J. Albu, Chair) |
| 17:30-19:30 |
Session I: 17:30 - 19:30
Assessment of Abdominal Obesity, Metabolic Syndrome and Related Cardiometabolic Risk P. Barter, Australia, J.P. Despres, Canada
17:30 - 17:45: Opening J.-P. Després, Canada, J. Chan, China, and J.C. Coubard, France
17:45 - 18:05: Abdominal Obesity and Insulin Resistance: An Epidemic Driving Residual CVD Risk P. Barter, Australia
18:05 - 18:25: The Metabolic Syndrome: Is It Useful? B. Brewer, USA
18:25 - 18:45: Ethnicity & Visceral Adiposity S. Lear, Canada
18:45 - 19:05: A Public Health Approach to Abdominal Obesity: The Japanese Experience T. Kadowaki, Japan
19:05 - 19:25: Abdominal Obesity, Type 2 Diabetes and Cardiometabolic Risk in Asia J.Chan, China
19:25 - 19:30: Closing Remarks P. Barter, Australia |
| 19:30-20:30 |
Opening and Welcome Reception - Sponsored by GSK |
Friday, January 29
| 06:00-07:00 |
Fun Run of 5km |
| 08:15-10:15 |
Session 2: 08:15 - 10:15
Pathophysiology of Abdominal Obesity and Related Cardiometabolic Risk
U. Smith, Sweden, M. Jensen, USA
08:15 - 08:45: Abdominal Obesity and Related Cardiometabolic Risk: An Update on the Endocannabinoid System V. DiMarzo, Italy
08:45 - 09:15: Plenary Lecture: Visceral Adiposity and Insulin Resistance; Lessons from the Dog R. Bergman
09:15 - 09:45: Visceral Adipose Tissue Metabolism in Human A. Tchernof, Canada
09:45 - 10:15: Ectopic Fat: An Important Feature of Visceral Obesity and Type 2 Diabetes M.R. Taskinen, Finland |
|
|
|
|
| 10:15-10:45 |
Coffee Break, Posters, Exhibition |
| 10:45-12:30 |
Session 2 Continued:
10:45 - 12:30
10:45 - 11:15: Visceral Adipose Tissue and Related Cardiometabolic Risk: Lessons from Framingham C. Fox, USA
11:15 - 11:45: Abdominal Adipose Tissue and Inflammation U. Smith, Sweden
11:45 - 12:15: Hypertriglyceridemic Waist: A Simple Clinical Tool for a Better Assessment of Cardiometabolic Risk J.-P. Després, Canada
12:15 - 12:30: Panel Discussion |
|
|
|
| 12:30:13:30 |
Lunch, Posters, Exhibition |
| 13:30-17:15 |
Session 3: 13:30 - 15:30
Assessment of Global Cardiometabolic Risk P. Libby, USA, B Brewer, USA
13:30 - 14:00: Abdominal obesity,type 2 diabetes and cardiovascular disease: is inflammation the missing link? P. Libby, USA
14:00 - 14:30: Framingham P. Wilson, USA
14:30 - 15:00: EPIC-Norfolk N. Wareham, UK
15:00 - 15:30: Physicians and Nurses Health Studies F.Hu, USA |
|
|
|
|
|
| 15:30-16:00 |
Coffee Break, Posters, Exhibition |
| 16:00-17:15 |
Session 3 Continued:
16:00 - 17:15
16:00 - 16:30: ARIC C. Ballantyne, USA
16:30 - 17:00: Translating Risk Assessment for the Patient M. Cobain, UK
17:00 - 17:15: Panel Discussion |
|
|
Saturday, January 30
| 8:00-10:30 |
Session 4: 08:00 - 10:30
Drivers of CVD Risk in Abdominal Obesity and Type 2 Diabetes
L. Van Gaal, Belgium and C. Ballantyne, USA
08:00 - 08:30: Plenary Lecture: Targeting Abdominal Obesity in Diabetology; What Can We Do? L. Van Gaal, Belgium
08:30 - 08:50: The Obesity Specialist Perspective M. Jensen, USA
08:50 - 09:10: The Lipidologist Perspective B. Brewer, USA
09:10 - 09:30: The View of the Hypertension Expert A. Sharma, Canada
09:30 - 09:50: The Cardiologist Perspective P. Poirier, Canada
09:50 - 10:10: The Heart Surgeon Perspective P. Mathieu, Canada
10:10 - 10:30: Panel Discussion |
|
|
|
|
|
| 10:30-11:00 |
Coffee Break, Posters, Exhibition |
| 11:00-13:00 |
Session 5: 11:00 - 13:00
Management of Abdominal Obesity and Global Cardiometabolic Risk: Physical Activity/Exercise J.-P. Després, Canada, M. Taskinen, Finland
11:00 - 11:45: Physical Activity/Exercize in the Management of Abdominal Obesity R. Ross, Canada
11:45 - 12:10: The Look-AHEAD Trial: An Update D. Ryan, USA
12:10 - 12:40: Can We Prevent Type 2 Diabetes? N. Wareham, UK
12:40 - 13:00 Panel Discussion |
|
|
|
|
| 13:00-14:00 |
Lunch, Posters, Exhibition |
| 14:00-15:40 |
Session 6: 14:00 - 15:40
Nutritional Management of Abdominal Obesity and Type 2 Diabetes: From Dieting to Eating Healthy R. Krauss, USA , J. Chan, Hong Kong
14:00 - 14:30: Reshaping Nutritional and Physical Activity Habits in Clinical Practice: The Synergie Study J.-P. Després, Canada
14:30 - 14:50: Nutritional Management of Patients with the Atherogenic Dyslipidemia of the Metabolic Syndrome R. Krauss, USA
14:50 - 15:10: Improving Diet Quality and Energy Density: From the Glycemic Index to the Portfolio Diet D. Jenkins, Canada
15:10 - 15:40: Healthy Drinking: An Important Component of Healthy Lifestyle B. Popkin, USA |
|
|
|
|
| 15:40-16:10 |
Coffee Break, Posters, Exhibition |
| 16:10-17:30 |
Session 6 Continued:
16:10 - 17:30
16:10 - 16:40: Sugar Supplemented Beverages in Type 2 Diabetes and CVD F. Hu, USA
16:40 - 17:00: Panel Discussion
17:00 - 17:30: Meeting Summary/Take-Home Messages J.-P. Després, Canada, P. Barter, Australia |
|
|
| 17:30 |
Adjourn |
|
|
|
|
|
|